Discontinued — last reported Q1 '18
Adobe Allowance for Doubtful Accounts Receivable (Current) decreased by 7.7% to $12.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 20.0%, from $15.00M to $12.00M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows a downward trend with a -9.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.00M | $17.00M | $16.00M | $18.00M | $19.00M | $24.00M | $23.00M | $17.00M | $17.00M | $18.00M | $16.00M | $16.00M | $19.00M | $17.00M | $14.00M | $15.00M | $16.00M | $14.00M | $13.00M | $12.00M |
| QoQ Change | — | -10.5% | -5.9% | +12.5% | +5.6% | +26.3% | -4.2% | -26.1% | +0.0% | +5.9% | -11.1% | +0.0% | +18.8% | -10.5% | -17.6% | +7.1% | +6.7% | -12.5% | -7.1% | -7.7% |
| YoY Change | — | — | — | — | +0.0% | +41.2% | +43.8% | -5.6% | -10.5% | -25.0% | -30.4% | -5.9% | +11.8% | -5.6% | -12.5% | -6.3% | -15.8% | -17.6% | -7.1% | -20.0% |